Posts by: Joana Carvalho

News

A combination of androgen deprivation therapy (ADT) and external beam radiation therapy (EBRT) is better at delaying disease progression and extending survival of patients with locally advanced prostate cancer ... Read more

April 10, 2019

Web-based PREDICT Prostate Tool Provides Personalized Cancer Prognosis

News

A new web-based tool, called PREDICT Prostate, incorporates patients’ clinical and demographic data to provide a personalized prognosis to men with prostate cancer, helping them choose between radical treatment ... Read more

April 8, 2019

Prostate Cancer Foundation Announces Scholar-in-Training Award Winners

News

The Prostate Cancer Foundation (PCF) has announced the winners of the Scholar-in-Training Awards — research grants to support young scientists who presented outstanding data in the field of prostate ... Read more

February 13, 2019

Grants Will Fuel UK Researchers’ Drive Toward Prostate Cancer-Killing Virus

News

Scientists from the Queen Mary University of London have received grants worth more than £2.5 million ($3.2 million), awarded by Prostate Cancer UK to advance prostate cancer research. The funds, which ... Read more

September 27, 2018

Tumor-fighting Protein, PTEN, Restored in Mice Prostate Cancer Models Using mRNA and Nanoparticles

News

Messenger RNAs encoding for the PTEN protein that were carried in tiny nanoparticles to prostate cancer cells in a proof-of-concept study were able to destroy those cells, preventing tumor growth and progression in several mouse ... Read more

July 19, 2018July 19, 2018

$26.5M Study to Look at Why Black Men at Higher Risk for Aggressive Prostate Cancer

News

The National Institutes of Health (NIH) and the Prostate Cancer Foundation launched a $26.5 million large-scale, multi-institutional study to assess how biological and social factors could be associated with aggressive ... Read more

July 2, 2018

TOOKAD Reduced Disease Worsening in Low-risk Prostate Cancer Patients After 4 Years, Study Found

News

Steba Biotech‘s TOOKAD treatment significantly reduces overall disease progression in men with low-risk prostate cancer, eliminating the need for most low-risk patients to undergo radical therapy, according to four-year ... Read more

June 25, 2018June 25, 2018

UT Southwestern Tests New Technique to Preserve Potency in Radiation Therapy Patients

News

UT Southwestern is conducting a multicenter clinical trial to test a new technique designed to spare nerves and arteries involved in sexual function to preserve potency in men receiving ... Read more

June 21, 2018

Axumin PET/CT Scans Lead to Treatment Changes in Most Recurring Prostate Cancer Patients, Phase 3 Trial Shows

News

In men suspected of recurring prostate cancer, imaging with Axumin (18F-fluciclovine) was able to accurately reveal sites of recurrence, which led to a change of treatment plans for 59 percent of ... Read more

Posts by: Joana Carvalho

Joana Carvalho

Radiation, Hormone Therapy Extend Survival in Advanced PC, Phase 3 Trial Shows

Web-based PREDICT Prostate Tool Provides Personalized Cancer Prognosis

Prostate Cancer Foundation Announces Scholar-in-Training Award Winners

Grants Will Fuel UK Researchers’ Drive Toward Prostate Cancer-Killing Virus

Tumor-fighting Protein, PTEN, Restored in Mice Prostate Cancer Models Using mRNA and Nanoparticles

$26.5M Study to Look at Why Black Men at Higher Risk for Aggressive Prostate Cancer

TOOKAD Reduced Disease Worsening in Low-risk Prostate Cancer Patients After 4 Years, Study Found

UT Southwestern Tests New Technique to Preserve Potency in Radiation Therapy Patients

Axumin PET/CT Scans Lead to Treatment Changes in Most Recurring Prostate Cancer Patients, Phase 3 Trial Shows

Pin It on Pinterest